412 related articles for article (PubMed ID: 1873079)
1. Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa).
Dumas M; Houinato D; Verdier M; Zohoun T; Josse R; Bonis J; Zohoun I; Massougbodji A; Denis F
AIDS Res Hum Retroviruses; 1991 May; 7(5):447-51. PubMed ID: 1873079
[TBL] [Abstract][Full Text] [Related]
2. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
3. Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users.
Aboulafia DM; Feigal E; Vranzian K; Bennett C; Blattner W; Moss A; Slamon D
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1043-50. PubMed ID: 7904169
[TBL] [Abstract][Full Text] [Related]
4. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
5. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
6. Human T cell lymphotropic virus type 1 in Zimbabwe.
Houston S; Thornton C; Emmanuel J; Latif A
Trans R Soc Trop Med Hyg; 1994; 88(2):170-2. PubMed ID: 8036662
[TBL] [Abstract][Full Text] [Related]
7. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S
Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic challenges: lymphotropic sero-"questionables".
Fox E; Constantine NT; Rodier G; Abbatte EA
East Afr Med J; 1992 Oct; 69(10):563-5. PubMed ID: 1473510
[TBL] [Abstract][Full Text] [Related]
9. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994.
Broutet N; de Queiroz Sousa A; Basilio FP; Sá HL; Simon F; Dabis F
Int J STD AIDS; 1996; 7(5):365-9. PubMed ID: 8894828
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.
Xie J; Ge S; Zhang Y; Lin Y; Ni H; Zhang J; Chen C
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of antibodies to the human T lymphotropic virus (HTLV) in Ghana, West Africa.
Biggar RJ; Neequaye JE; Neequaye AR; Ankra-Badu GA; Levine PH; Manns A; Taylor M; Drummond J; Waters D
AIDS Res Hum Retroviruses; 1993 Jun; 9(6):505-11. PubMed ID: 8347395
[TBL] [Abstract][Full Text] [Related]
14. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.
de Araujo AC; Casseb JS; Neitzert E; de Souza ML; Mammano F; Del Mistro A; De Rossi A; Chieco-Bianchi L
Eur J Epidemiol; 1994 Apr; 10(2):165-71. PubMed ID: 7813694
[TBL] [Abstract][Full Text] [Related]
15. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.
Khameneh ZR; Baradaran M; Sepehrvand N
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):838-41. PubMed ID: 18711311
[TBL] [Abstract][Full Text] [Related]
16. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
[TBL] [Abstract][Full Text] [Related]
17. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
19. Selectivity of human T lymphotropic virus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil.
Gabbai AA; Bordin JO; Vieira-Filho JP; Kuroda A; Oliveira AS; Cruz MV; Ribeiro AA; Delaney SR; Henrard DR; Rosario J
Am J Trop Med Hyg; 1993 Dec; 49(6):664-71. PubMed ID: 8279633
[TBL] [Abstract][Full Text] [Related]
20. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China.
Zhao J; Zhao F; Han W; Xu X; Wang L; Li R; Li T; Wu L; Du D; Zeng X; Cui X; Chen Y; Zeng J; Wang L
BMC Infect Dis; 2020 Aug; 20(1):581. PubMed ID: 32762656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
